99 related articles for article (PubMed ID: 20415488)
21. Discovery and optimization of boronic acid based inhibitors of autotaxin.
Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H
J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182
[TBL] [Abstract][Full Text] [Related]
22. Specific increase in serum autotaxin activity in patients with pancreatic cancer.
Nakai Y; Ikeda H; Nakamura K; Kume Y; Fujishiro M; Sasahira N; Hirano K; Isayama H; Tada M; Kawabe T; Komatsu Y; Omata M; Aoki J; Koike K; Yatomi Y
Clin Biochem; 2011 Jun; 44(8-9):576-81. PubMed ID: 21439952
[TBL] [Abstract][Full Text] [Related]
23. Lysophospholipase D and its role in LPA production.
Xie Y; Meier KE
Cell Signal; 2004 Sep; 16(9):975-81. PubMed ID: 15212758
[TBL] [Abstract][Full Text] [Related]
24. Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.
North EJ; Howard AL; Wanjala IW; Pham TC; Baker DL; Parrill AL
J Med Chem; 2010 Apr; 53(8):3095-105. PubMed ID: 20349977
[TBL] [Abstract][Full Text] [Related]
25. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells.
Haga A; Hashimoto K; Tanaka N; Nakamura KT; Deyashiki Y
Protein Expr Purif; 2008 May; 59(1):9-17. PubMed ID: 18249559
[TBL] [Abstract][Full Text] [Related]
26. Lysophospholipids in the limelight: autotaxin takes center stage.
Moolenaar WH
J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
[TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells.
Li S; Zhang J
Biochem Biophys Res Commun; 2009 Jan; 378(2):264-8. PubMed ID: 19027716
[TBL] [Abstract][Full Text] [Related]
28. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
[TBL] [Abstract][Full Text] [Related]
29. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.
Block RC; Duff R; Lawrence P; Kakinami L; Brenna JT; Shearer GC; Meednu N; Mousa S; Friedman A; Harris WS; Larson M; Georas S
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):87-95. PubMed ID: 20106646
[TBL] [Abstract][Full Text] [Related]
30. Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase.
Pradère JP; Tarnus E; Grès S; Valet P; Saulnier-Blache JS
Biochim Biophys Acta; 2007 Jan; 1771(1):93-102. PubMed ID: 17208043
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Gendaszewska-Darmach E
Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
[TBL] [Abstract][Full Text] [Related]
32. Optimization of a pipemidic acid autotaxin inhibitor.
Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL
J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX).
East JE; Kennedy AJ; Tomsig JL; De Leon AR; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2010 Dec; 20(23):7132-6. PubMed ID: 20951039
[TBL] [Abstract][Full Text] [Related]
34. Mediators of pruritus during cholestasis.
Oude Elferink RP; Kremer AE; Beuers U
Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
[TBL] [Abstract][Full Text] [Related]
35. Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white.
Morishige J; Touchika K; Tanaka T; Satouchi K; Fukuzawa K; Tokumura A
Biochim Biophys Acta; 2007 Apr; 1771(4):491-9. PubMed ID: 17321793
[TBL] [Abstract][Full Text] [Related]
36. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.
Billon-Denis E; Tanfin Z; Robin P
J Lipid Res; 2008 Feb; 49(2):295-307. PubMed ID: 18024704
[TBL] [Abstract][Full Text] [Related]
37. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids.
Nakamura K; Kishimoto T; Ohkawa R; Okubo S; Tozuka M; Yokota H; Ikeda H; Ohshima N; Mizuno K; Yatomi Y
Anal Biochem; 2007 Aug; 367(1):20-7. PubMed ID: 17568554
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of lysophosphatidic acid production.
Aoki J
Semin Cell Dev Biol; 2004 Oct; 15(5):477-89. PubMed ID: 15271293
[TBL] [Abstract][Full Text] [Related]
39. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML
Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
